R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

The opportunities and challenges facing rare disease therapi...

To mark upcoming Rare Disease Day, pharmaphorum asked a panel of experts to give their thoughts on the opportunities and challenges facing developers of rare disease therapies in 2024.

R&D

diagnostics device for multiple conditions

In search of the fabled tricorder

When two or more people from the world of medical technology meet, talk inevitably turns to the ongoing, yet elusive, search for an industry-standard, multi-disciplinary diagnostic device –

R&D

This week in clinical trials: 29th January to 2nd February

Continuing our weekly clinical trial round-ups, here we look at developments in life sciences research and development announced during the week of 29th January to 2nd

R&D

Applying genetics to chemistry to find new small molecules

For all the advances that have been made in it, drug discovery is still a hit or miss process, as much an art as a science.

R&D

JP Morgan 2024 – Sam Deutsch

In another lightning round JP Morgan interview, editor-in-chief Jonah Comstock caught up with Sam Deutsch, CEO of Nutcracker Therapeutics, to talk briefly about the company’s lead asset for cervica

R&D